Health
FDA approves generic version of twice-yearly HIV-prevention injection lenacapavir
The U.S. Food and Drug Administration has approved a generic version of the HIV-prevention shot lenacapavir, which the AP calls a "cheap version" and STAT News describes as a tentative approval aimed at widening access in low- and middle-income countries.